You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
|
|---|---|
| Published in |
Nature Reviews Cancer, May 2013
|
| DOI | 10.1038/nrc3526 |
| Pubmed ID | |
| Authors |
Nai-Kong V. Cheung, Michael A. Dyer |
| Abstract |
Neuroblastoma is a solid tumour that arises from the developing sympathetic nervous system. Over the past decade, our understanding of this disease has advanced tremendously. The future challenge is to apply the knowledge gained to developing risk-based therapies and, ultimately, improving outcome. In this Review we discuss the key discoveries in the developmental biology, molecular genetics and immunology of neuroblastoma, as well as new translational tools for bringing these promising scientific advances into the clinic. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| Japan | 1 | 20% |
| United Kingdom | 1 | 20% |
| Mexico | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 741 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | <1% |
| United States | 3 | <1% |
| Malaysia | 2 | <1% |
| Sweden | 2 | <1% |
| United Kingdom | 2 | <1% |
| Italy | 2 | <1% |
| Ecuador | 2 | <1% |
| Austria | 1 | <1% |
| France | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 718 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 136 | 18% |
| Student > Master | 102 | 14% |
| Researcher | 99 | 13% |
| Student > Bachelor | 98 | 13% |
| Student > Doctoral Student | 42 | 6% |
| Other | 130 | 18% |
| Unknown | 134 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 191 | 26% |
| Agricultural and Biological Sciences | 151 | 20% |
| Medicine and Dentistry | 143 | 19% |
| Neuroscience | 19 | 3% |
| Immunology and Microbiology | 17 | 2% |
| Other | 71 | 10% |
| Unknown | 149 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2022.
All research outputs
#1,744,515
of 25,839,971 outputs
Outputs from Nature Reviews Cancer
#606
of 2,497 outputs
Outputs of similar age
#14,079
of 208,980 outputs
Outputs of similar age from Nature Reviews Cancer
#7
of 34 outputs
Altmetric has tracked 25,839,971 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,497 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,980 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.